Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2007
10/16/2007US7282351 Prostatic growth factor
10/16/2007US7282347 Measurement of interactions between two proteinaceous components in a cell; extraction buffer used in high throughput screening for drugs that affect the intracellular distribution of intracellular components
10/16/2007US7282334 Method for in vitro molecular evolution of protein function
10/16/2007US7282333 Methods and compositions for nucleic acid analysis
10/16/2007US7282331 Using fluorescence in-situ hybridization to detect gene sequences associated with infection, cell proliferative, respiratory and blood disorders
10/16/2007US7282330 Methods and apparati using single polymer analysis
10/16/2007US7282329 label-free detector for measuring a property of an analyte; comprises at least one suspended beam connected to two mechanically stable supports; micro-electro-mechanical system (MEMS)
10/16/2007US7282328 Helicase dependent amplification of nucleic acids
10/16/2007US7282327 Pyrimidine base containing compound suitable for enzymatic attachment to a nucleic acid, to provide a mechanism of nucleic acid detection
10/16/2007US7282326 Recombinational cloning using engineered recombination sites
10/16/2007US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
10/11/2007WO2007115265A2 Reagents useful for synthesizing rhodamine-labeled oligonucleotides
10/11/2007WO2007115175A2 Cyclic natriuretic peptide constructs
10/11/2007WO2007047243A3 Methods of diagnosing cardiovascular disease
10/11/2007WO2007024368A3 Compositions and methods to control angiogenesis with cupredoxins
10/11/2007WO2006136411A8 Nucleolipids and use thereof, and devices for nucleic acid analysis
10/11/2007WO2006113426A3 Cancer treatment by combined inhibition of telomerase and tubulin activities
10/11/2007WO2006096392A3 Enzymes involved in astaxanthin, carotenoid and isoprenoid biosynthetic pathways, genes encoding them and methods of making and using them
10/11/2007WO2006076142A3 Method and apparatus for chromosome profiling
10/11/2007WO2005115394A3 Prenyl-electrostatic switch, and methods of use
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007US20070240239 Axmi-003, a delta-endotoxin gene and methods for its use
10/11/2007US20070240237 Pesticidal Vip3 toxins toxin from Bacillus thuringiensis highly active against a wide range of lepidopteran insect pests is disclosed. The DNA encoding the pesticidal toxin; used to transform various prokaryotic and eukaryotic organisms to express the pesticidal toxin;crops; genetic engineering
10/11/2007US20070238890 transgenic oil palm comprising a recombined nucleic acid that is selectively expressed in the mesocarp, wherein the expression is regulated by an MT3-A regulatory nucleic acid; regulate gene expression in the mesocarp and/or senescent leaves of certain plants
10/11/2007US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007US20070238868 siRNA targeting chemokine (C-X-C motif) receptor 4 (CXCR4)
10/11/2007US20070238859 Wound healing agents; anticancer agents; cardiovascular disorders
10/11/2007US20070238690 Modulation of glucagon receptor expression
10/11/2007US20070238689 Modulation of glucagon receptor expression
10/11/2007US20070238688 Modulation of glucagon receptor expression
10/11/2007US20070238687 Modulation of glucagon receptor expression
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238681 Modulation of ace2 expression
10/11/2007US20070238678 Methods and compositions for inhibition of innate immune responses and autoimmunity
10/11/2007US20070238676 Polynucleotides for Reducing Respiratory Syncytial Virus Gene Expression
10/11/2007US20070238675 Stem Cell Beacon
10/11/2007US20070238664 70 Human Secreted Proteins
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238646 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238642 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
10/11/2007US20070238638 Bak promoter expression system
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238179 Cell Division and Proliferation Preferred Regulatory Elements and Uses Thereof
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070238168 Double mutant alpha-7 nicotinic acetylcholine receptor
10/11/2007US20070238155 Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
10/11/2007US20070238154 Humanized antibodies that recognize beta-amyloid peptide
10/11/2007US20070238153 Processes for improved disulfide bond formation in recombinant systems
10/11/2007US20070238151 Novel compounds
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238149 nucleotide sequences that code for polypeptides having oxidoreductase enzyme activity useful for biosynthesis of astaxanthin
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238134 Cell cycle proteins associated with rad9, compositions and methods of use
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070238118 Methods and kits for sequentially isolating rna and genomic dna from cells
10/11/2007US20070238116 Oligonucleotide primer for rapid identification and quantification of microorganisms associated with blood toxemia
10/11/2007US20070238110 using molecular markers for identifying potential bovine carriers of the dwarfism mutation and for identifying the genetic locus and mutations thereof responsible for dwarfism and genetic markers test for assaying for the same
10/11/2007US20070238103 predicting clinical responsiveness to methotrexate therapy in a human afflicted with, or at risk of developing, rheumatoid arthritis ; antifolate methotrexate
10/11/2007US20070238101 Nucleic acid interaction analysis
10/11/2007US20070238100 Integrated methodologies for the detection and genotyping of human papillomaviruses
10/11/2007US20070238099 Antigen Receptor Variable Region Typing
10/11/2007US20070238096 Hybrid energy transfer for nucleic acid detection
10/11/2007US20070238095 Detection of Influenza A Virus
10/11/2007US20070238093 Detection of influenza A virus
10/11/2007US20070238086 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
10/11/2007US20070237813 Cancer-suppressing agents
10/11/2007US20070237794 Compounds and Methods for Diagnosis and Treatment of Leishmaniasis
10/11/2007US20070237791 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (cfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E.coli
10/11/2007US20070237776 Binds to hIL-18R alpha with high affinity and by the ability to neutralize hIL-18 activity, including IL-18-induced interferon gamma expression and IL-18-induced cellular activation; sepsis; cardiovascular disorders; liver injury; arthritis, including rheumatoid arthritis; inflammatory bowel diseases
10/11/2007US20070237769 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
10/11/2007US20070237764 Binding polypeptides with restricted diversity sequences
10/11/2007US20070237761 Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia
10/11/2007US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007US20070237717 Methods for Selection of Subjects for Multiple Sclerosis Therapy
10/11/2007CA2649045A1 Pharmaceutical composition
10/11/2007CA2648132A1 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
10/11/2007CA2647728A1 Compositions and methods for inhibiting expression of eg5 gene
10/11/2007CA2645015A1 Methylation of genes as a predictor of polyp formation and recurrence
10/11/2007CA2585047A1 Method for quick determination of cytokeratin 19 (ck19) and primers and probes therefore
10/10/2007EP1842923A1 Methanesulfonylaminoindole derivatives and labeled oligonucleotide probes containing them.
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842552A1 Treatment for diabetes
10/10/2007EP1841890A2 Primer for nucleic acid detection
10/10/2007EP1841868A2 Inhibitor nucleic acids
10/10/2007EP1841865A2 Inducible sirna expression cassette and method of use
10/10/2007EP1841794A2 Adam-9 modulators
10/10/2007EP1841777A1 Oligonucleotides derived from mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell
10/10/2007EP1841463A2 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
10/10/2007EP1664350A4 Method for small volume nucleic acid synthesis
10/10/2007EP1649065A4 Methods for amplifying polymeric nucleic acids
10/10/2007EP1620452A4 Treatment of nucleic acid
10/10/2007EP1573036A4 Subtelomeric dna probes and method of producing the same
10/10/2007EP1311853B1 Combination of microporous membrane and solid support for microdiagnostics
10/10/2007EP1181304B1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/10/2007EP0832287B1 Oligonucleotide tags for sorting and identification
10/10/2007CN101052726A IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/10/2007CN101052644A RNAi therapeutics for treatment of eye neovascularization diseases
10/10/2007CN101052643A Methods and compositions for inhibition of innate immune responses and autoimmunity